These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20597655)

  • 21. [Clinical bacteriology and empiric therapy for hospital-acquired pneumonia in the elderly at a national leprosarium].
    Matsui S; Nakazawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Sep; 32(9):851-5. PubMed ID: 7799554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics in childhood pneumonia.
    Hale KA; Isaacs D
    Paediatr Respir Rev; 2006 Jun; 7(2):145-51. PubMed ID: 16765302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Issues in the design of clinical trials for antibacterial drugs for hospital-acquired pneumonia and ventilator‐associated pneumonia. Proceedings of a workshop co-sponsored by the US Food and Drug Administration, Infectious Diseases Society of America, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine. March 31-April 1 2009.
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-170. PubMed ID: 21058464
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
    Bassetti M; Righi E; Rosso R; Mannelli S; Di Biagio A; Fasce R; Pallavicini FB; Marchetti F; Viscoli C
    Int J Antimicrob Agents; 2006 Dec; 28(6):582-5. PubMed ID: 16979877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!
    Ambrose PG; Bhavnani SM; Ellis-Grosse EJ; Drusano GL
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S103-10. PubMed ID: 20597657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An antimicrobial approach to nosocomial pneumonia.
    Niederman MS
    Contemp Intern Med; 1995 Mar; 7(3):9-14, 19-23. PubMed ID: 10150342
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trial design for mild-to-moderate community-acquired pneumonia--an industry perspective.
    Echols RM; Tillotson GS; Song JX; Tosiello RL
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S166-75. PubMed ID: 18986284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of nursing home-acquired pneumonia.
    Mills K; Graham AC; Winslow BT; Springer KL
    Am Fam Physician; 2009 Jun; 79(11):976-82. PubMed ID: 19514695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of Corynebacterium pseudodiphtheriticum nosocomial pneumonia.
    Martaresche C; Fournier PE; Jacomo V; Gainnier M; Boussuge A; Drancourt M
    Emerg Infect Dis; 1999; 5(5):722-3. PubMed ID: 10610204
    [No Abstract]   [Full Text] [Related]  

  • 31. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
    Kim A; Kuti JL; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit.
    McMullin BB; Chittock DR; Roscoe DL; Garcha H; Wang L; Miller CC
    Respir Care; 2005 Nov; 50(11):1451-6. PubMed ID: 16253152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
    McClure JR; Cooke RP; Lal P; Pickles D; Majjid S; Grant CA; Jones TM; Dempsey GA
    J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Uncomplicated community-acquired pneumonia. Under control in 3 treatment days].
    MMW Fortschr Med; 2003 Jan; 145(3-4):58. PubMed ID: 12619240
    [No Abstract]   [Full Text] [Related]  

  • 36. Is it possible to blind a trial for community-acquired pneumonia?
    Boucher HW
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S210-5. PubMed ID: 18986292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical end points of therapy for patients with mild community-acquired pneumonia.
    Gilbert DN
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S140-4. PubMed ID: 18986280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
    Motaouakkil S; Charra B; Hachimi A; Benslama A
    Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etiology and diagnosis of pneumonia in patients on artificial lung ventilation].
    Khrapov KN; Pavlova EA; Kolesnik AV; Eremenko EA
    Anesteziol Reanimatol; 2001; (4):60-2. PubMed ID: 11586637
    [No Abstract]   [Full Text] [Related]  

  • 40. Nosocomial pneumonia: state of the science.
    Flanders SA; Collard HR; Saint S
    Am J Infect Control; 2006 Mar; 34(2):84-93. PubMed ID: 16490612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.